Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-11

Clinical Trial Update: Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of Tai-chi / Qi-gong for gynecologic cancers has been withdrawn; the study targeted ovarian cancer and primary peritoneal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sheba Medical Center | Conditions: Ovarian Cancer, Primary Peritoneal Cancer | Phase 1, Phase 2 | Status: WITHDRAWN